Of total patients, 345 (83.3%) were thrombolysed by streptokinase, and 69 (16.7%) by reteplase
(Table 1 and Figure 2).
Studies on reteplase
with abciximab provided optimistic results regarding the possibility of increasing reperfusion after AIS.
Conclusion: The oxidizing cytoplasm of Rosetta-gami and Shuffle T7 in addition to alterations of cultivation parameters could not result in soluble production of reteplase
, although the inclusion bodies produced in these two strains might increase the rate of refolding procedure likely due to formation of folding intermediates.
Sayah et al., "Evaluation of the time saved by prehospital initiation of reteplase
for ST-elevation myocardial infarction: results of the early retavase-thrombolysis in myocardial infarction (ER-TIMI) 19 trial," Journal of the American College of Cardiology, vol.
Samples treated with streptokinase, tenecteplase, and reteplase
did not yield a sufficient number of quality metaphases (less than 20 metaphases) for routine clinical analysis.
The efficacy of reteplase
in the treatment of thrombosed hemodialysis venous catheters.
, which also has a high molecular weight, treats acute MI and is not teratogenic in animals but was an abortifacient in rats and rabbits.
Cardiologists typically treat heart attacks with either thrombolytic drugs, such as reteplase
, to dissolve offending clots, or primary angioplasty, to clear the plaque producing the heart attack.
has no carbohydrate side chains and thus can be produced in E.
Similarly, Qureshi, Suri, Geogiadis, Vazquez, and Janjua (2009) performed a pool of four prospective studies to evaluate the following IA recanalization techniques: (a) IV rtPA and mechanical clot disruption with an Amplatz gooseneck microsnare, (b) IV Abciximab and IA Reteplase
, (c) EKOS MicroLys infusion catheter, and (d) IA Reteplase
and mechanical clot disruption with an Amplatz gooseneck microsnare, paying close attention to the following three factors: the effect of age of 80 years or older on angiographic recanalization, good outcomes as evidenced by mRS score, and rate of mortality at 1-3 months.
Following the stabilization with a pacing wire, the patient was thrombolyzed with intravenous reteplase
(10 units + 10 units, 30 minutes apart), followed by unfractionated heparin infusion (5000 units bolus + 1000 units/hour infusion).
So far, a variety of thrombolytic drugs have been used: tenecteplase (TNKase), reteplase
(Retavase), alteplase (Activase), and urokinase.